Nouscom promotes Richard Davis to COO
Nouscom has announced the immediate promotion of Richard (Rick) Davis, Ph.D. to Chief Operating Officer (COO). Rick will join Nouscom as Chief Business Officer in September 2020. Rick has over 20 years of experience in the life sciences industry, with a strong background in business development and investment, with a focus on strategic partnerships and growth strategies.
Nouscom is a next-generation immunotherapy company developing engineered viral vectored vaccines for the treatment of cancer.